A Michigan Medicine research team is raising concerns as a pending Supreme Court case threatens free hepatitis C screening, a critical tool for curing the disease. In a new article, U-M experts outline two futures: one where testing leads to elimination, and another where undiagnosed cases surge. A simple, one-time test could save thousands of lives and billions in healthcare costs—but only if it remains free under the Affordable Care Act. The Court’s decision could reshape efforts to eliminate this curable, yet deadly, disease. Read more about what’s at stake.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.